Stocks · Healthcare · Medical - Instruments & Supplies
Utah Medical Products, Inc. UTMD
$74.13 -0.30% Close, Oct 2, 2026 · NASDAQ · Market cap $236.0M
Low risk
Next earnings report: Oct 22, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The shares trade at 22.6× trailing earnings, higher than 90% of the company's own readings over the past five years.
- The stock is in an uptrend: above its 200-day average for 188 trading days, with the 50-day average above the 200-day.
- Revenue over the last four quarters was $36.1M, down 7.0% from a year earlier, slowing from -4.4% a quarter earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 22%
- EPS growth (TTM, YoY)Bottom 39%
- FCF growth (TTM, YoY)Bottom 26%
- Revenue growth, 3-year CAGRBottom 11%
- Revenue growth accelerationBottom 33%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 20%
- Gross marginBottom 40%
- Operating marginTop 8%
- Cash conversion (OCF / net income)Bottom 27%
- Accruals (lower is better)Bottom 20%
- Net debt / EBITDA (lower is better)Top 35%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 12%
- Free-cash-flow yieldTop 18%
- EBITDA / enterprise valueTop 19%
- Sales / enterprise valueBottom 41%
- P/E vs own 5-year history (lower is better)Bottom 11%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 43%
- 6-month returnTop 41%
- 1-year return vs S&P 500Top 46%
- Distance from 52-week highTop 3%
- Trend checklist (0–4)Top 7%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 19%
- Consecutive EPS beatsBottom 20%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 12%
- Maximum drawdown, 3 yearsTop 15%
- Beta vs S&P 500 (lower is better)Top 16%
- Net debt / EBITDA (lower is better)Top 35%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -4.4% | -7.0% | ↓ |
| EPS growth (YoY) | -10.6% | -12.3% | ↓ |
| Gross margin | 54.6% | 54.9% | ↑ |
| Operating margin | 32.5% | 28.5% | ↓ |
| FCF margin | 36.1% | 31.7% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -7.0% | -4.4% | ↓ | Bottom 22% |
| EPS growth (TTM, YoY) | -12.3% | -10.6% | ↓ | Bottom 39% |
| Gross margin | 54.9% | 54.6% | ↑ | Bottom 40% |
| Operating margin | 28.5% | 32.5% | ↓ | Top 8% |
| Net margin | 29.0% | 32.3% | ↓ | — |
| Free-cash-flow margin | 31.7% | 36.1% | ↓ | — |
| Return on invested capital | 6.8% | — | Top 20% | |
| Revenue growth, 3-year CAGR | -9.7% | — | Bottom 11% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.13×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -1.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.1%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +5.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 0.01×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 1.67%
- Net buyback yield (TTM)
- 0.79%
- Shareholder yield
- 2.45%
- Share count change, 1 year
- -1.9%
- Share count change, 3-year CAGR
- -4.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 12, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 0 of 1
- Average EPS surprise, last 4
- -25.3%
- Average 2-day reaction, last 8
- -1.4%
- Positive 20 days after report
- 3 of 8
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 23, 2026 | — | -7.2% | +2.5% | +4.2% | — |
| Apr 23, 2026 | — | -2.5% | -6.6% | -7.8% | -0.5% |
| Jan 29, 2026 | — | +1.3% | +1.7% | +9.4% | +10.4% |
| Oct 23, 2025 | — | -0.9% | -6.6% | -11.7% | +0.5% |
| Jul 24, 2025 | — | -0.2% | -3.1% | -0.6% | +3.3% |
| Apr 29, 2025 | — | +0.6% | +0.2% | +4.7% | +11.2% |
| Mar 26, 2025 | — | -0.1% | -1.3% | -6.2% | -5.5% |
| Jan 28, 2025 | — | -1.8% | -6.6% | -6.6% | -17.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 23, 2026 | $0.84 | — | — | $8.5M |
| Apr 23, 2026 | $0.82 | — | — | $8.7M |
| Jan 29, 2026 | $0.80 | — | — | $9.0M |
| Oct 23, 2025 | $0.82 | — | — | $9.8M |
| Jul 24, 2025 | $0.94 | — | — | $10.0M |
| Apr 29, 2025 | $0.92 | — | — | $9.7M |
| Mar 26, 2025 | $0.86 | — | — | $9.2M |
| Jan 28, 2025 | $0.86 | — | — | $10.0M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 22.6× | 18.9× | 90th | Top 12% |
| EV / EBITDA | 16.1× | — | — | Top 19% |
| EV / Sales | 6.54× | — | — | Bottom 41% |
| Free-cash-flow yield | 4.85% | — | — | Top 18% |
| Earnings yield | 4.42% | — | — | Top 12% |
P/E over the past five years
Range 14.4× – 28.2× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +16.3%
- Earnings per share growth (TTM)
- -12.3%
- Change in P/E multiple
- +42.8%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 15
- Days above the 200-day average
- 188
- 50-day average slope (20 days)
- +2.0%
- 200-day average slope (20 days)
- +2.7%
- Distance from 50-day average
- +3.0%
- Distance from 200-day average
- +11.5%
- RSI (14)
- 54.8
- Relative volume
- 0.55×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 31.5%
- Volatility vs own 5-year history
- 75th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.50
- Correlation with S&P 500
- 0.33
- Current drawdown from 1-year high
- -3.3%
- Maximum drawdown, 3 years
- -41.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 22, 2021 | Apr 30, 2025 | -58.5% | 861 days | Not yet recovered |
| Dec 8, 2020 | Jun 8, 2021 | -12.7% | 124 days | 75 days (Sep 23, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $236.0M
- P/E (TTM)
- 22.6
- EPS, diluted (TTM)
- $3.28
- Revenue (TTM)
- $36.1M
- Dividend yield
- 1.67%
- 52-week range
- $53.66 – $76.89
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $49.1M | $52.3M | $50.2M | $40.9M | $38.5M |
| Gross profit | $30.9M | $32.2M | $30.0M | $24.1M | $19.9M |
| Operating income | $18.9M | $19.8M | $16.8M | $13.6M | $11.4M |
| Net income | $14.8M | $16.5M | $16.6M | $13.9M | $11.3M |
| EPS (diluted) | $4.04 | $4.52 | $4.57 | $3.96 | $3.48 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.0M | $9.2M | $9.7M | $10.0M | $9.8M | $9.0M | $8.7M | $8.5M |
| Net income | $3.6M | $2.9M | $3.0M | $3.0M | $2.6M | $2.6M | $2.6M | $2.7M |
| EPS (diluted) | $1.02 | $0.86 | $0.92 | $0.94 | $0.82 | $0.80 | $0.82 | $0.84 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $21.2M | $21.1M | $22.3M | $14.8M | $14.7M |
| Capital expenditure | -$552,000 | -$818,000 | -$639,000 | -$235,000 | -$371,000 |
| Free cash flow | $20.7M | $20.3M | $21.6M | $14.6M | $14.3M |
| Dividends paid | -$11.5M | -$3.2M | -$4.3M | -$4.3M | -$4.0M |
| Net share buybacks | $0 | -$2.5M | $0 | -$20.0M | -$8.4M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $87.5M
- Total assets
- $124.6M
- Total liabilities
- $2.5M
- Total debt
- $195,000
- Net debt
- $195,000
- Shareholders’ equity
- $122.0M
As of Jun 30, 2026 (filed Aug 12, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Sep 17, 2026 | $0.31 | Oct 5, 2026 |
| Jun 17, 2026 | $0.31 | Jul 3, 2026 |
| Mar 17, 2026 | $0.31 | Apr 3, 2026 |
| Dec 16, 2025 | $0.31 | Jan 5, 2026 |
| Sep 17, 2025 | $0.31 | Oct 2, 2025 |
| Jun 16, 2025 | $0.31 | Jul 3, 2025 |
| Mar 14, 2025 | $0.31 | Apr 3, 2025 |
| Dec 16, 2024 | $0.31 | Jan 3, 2025 |
Short interest
- Shares sold short
- 172,180
- Days to cover
- 4.53
- Change vs previous report
- +3.2%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Mar 22, 1993
- 3-for-2